BioSig Technologies ( (BSGM) ) has released a notification of late filing.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
BioSig Technologies, Inc. has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending March 31, 2025. The company cites time constraints in compiling, disseminating, and reviewing the necessary financial information as the primary reason for the delay. BioSig Technologies anticipates filing the report no later than the fifth calendar day following the prescribed due date. The company expects significant changes in its financial results, with a notable decrease in research and development expenses compared to the previous year. However, the preliminary financial information remains subject to change pending the completion of the financial statements. BioSig Technologies is committed to ongoing compliance efforts, as indicated by the notification signed by Ferdinand Groenewald, the Interim Chief Financial Officer.
The most recent analyst rating on (BSGM) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on BioSig Technologies stock, see the BSGM Stock Forecast page.
Spark’s Take on BSGM Stock
According to Spark, TipRanks’ AI Analyst, BSGM is a Underperform.
BioSig Technologies faces significant financial difficulties, with persistent losses, high leverage, and negative cash flow trends. While technical analysis indicates some short-term momentum, potential overbought conditions warrant caution. The negative P/E ratio further underscores valuation challenges and risks associated with the stock.
To see Spark’s full report on BSGM stock, click here.
More about BioSig Technologies
Average Trading Volume: 461,496
Technical Sentiment Signal: Buy
Current Market Cap: $61.12M
See more insights into BSGM stock on TipRanks’ Stock Analysis page.